Regulator actions, recalls, seizures, trial results and press coverage go here. One story per thread.
A good news post has
- A plain title with the who, what and date. No all-caps, no alarm words.
- The primary source: the agency notice, the trial registry entry, the paper or the company release. A news article is fine as a second link.
- Two or three sentences in your own words: what happened, who it applies to and what is still unknown.
- What it does not establish. A committee vote is not a final rule. A press release is not a peer-reviewed result. A seizure notice about one seller says nothing about others.
Where to look things up
- US compounding status for FDA category decisions.
- Registered clinical trials for trial phases and posted results.
- The research library for the papers behind each compound.
News about one vendor (a closure, a ban, a batch problem) belongs in Vendor Experiences or Scam Alerts so people searching that vendor find it.
The Community Rules apply here: research discussion only, no dosing or personal-use advice, no buying, selling or sourcing requests, and disclose any vendor connection.